| 3/18/2024 | BKCV | Fitch assigns Kaman B+, loans BB
|
| 7/24/2023 | BKCV | S&P snips Kaman
|
| 6/9/2022 | BKCV | S&P cuts Kaman
|
| 3/8/2022 | BKCV | S&P shifts Kaman view to stable
|
| 9/27/2019 | CVLM | Kaman says holders of $500,000 3.25% convertibles exercise put option
|
| 8/29/2019 | CV | Market Commentary: Kaman 3.25% convertibles in focus; trading light as many underlying shares strengthen
|
| 8/29/2019 | CV | Market Commentary: Morning Commentary: Kaman 3.25% convertibles in focus; many underlying shares gain
|
| 8/29/2019 | CVLM | Kaman offers to repurchase or convert 3.25% convertibles due 2024
|
| 8/26/2019 | BKCV | S&P lowers Kaman
|
| 7/16/2019 | CVLM | Kaman gets consents to amend 3.25% convertible notes due 2024
|
| 7/8/2019 | CVLM | Kaman launches consent solicitation for 3.25% convertibles due 2024
|
| 6/27/2019 | BKCV | S&P puts Kaman on negative watch
|
| 7/5/2018 | BKCV | S&P affirms Kaman
|
| 7/10/2017 | BKCV | S&P ups Kaman view to stable
|
| 7/5/2017 | CV | Kaman’s 3.25% notes due 2017 continue to be convertible until Nov. 13
|
| 5/25/2017 | CV | Kaman greenshoe lifts seven-year 3.25% convertibles to $200 million
|
| 5/12/2017 | CV | Market Commentary: Stanley Black & Decker notches strong debut; Dermira deal touted; Becton Dickinson does well
|
| 5/9/2017 | CV | Market Commentary: New deals from DexCom, Kaman active post-pricing; Dermira adds to calendar; Becton on tap
|
| 5/9/2017 | CV | Market Commentary: Morning Commentary: New issues from DexCom, Kaman climb above par in active trading
|
| 5/9/2017 | CV | New Issue: Kaman sells $175 million seven-year convertibles at 3.25%, up 25%
|
| 5/8/2017 | CV | Market Commentary: DexCom, Kaman, Becton Dickinson enter market; Horizon falters as guidance lowered; Cobalt up
|
| 5/8/2017 | CV | Market Commentary: Morning Commentary: DexCom, Kaman, Becton Dickinson plan to tap market; Horizon falters
|
| 5/8/2017 | CV | Kaman to sell $175 million seven-year convertible senior notes at 3.25%-3.75% yield, up 25%-30%
|
| 4/3/2017 | CV | Kaman’s 3.25% notes continue to be convertible in second quarter
|
| 1/12/2017 | CV | Kaman keeps conversion window open for 3.25% notes due 2017
|
| 10/3/2016 | CV | Kaman’s 3.25% notes due 2017 become convertible
|
| 11/9/2015 | BKCV | S&P trims Kaman view to negative
|
| 12/13/2013 | BKCVIG | S&P lowers Kaman to BB+
|
| 8/13/2012 | BKCV | S&P affirms Kaman
|
| 11/19/2010 | CV | Kaman greenshoe fully exercised, lifting convertibles to $115 million
|
| 11/16/2010 | CV | Market Commentary: Selling hits convertibles: Radian, NetApp lower dollar neutral; Regis skids; Kaman adds
|
| 11/15/2010 | CV | Market Commentary: Action muted ahead of GM deal; GM talk revised; Kaman quiet in the gray; RightNow on tap
|
| 11/15/2010 | CV | New Issue: Kaman prices $100 million of seven-year convertible notes to yield 3.25%, up 30%
|
| 6/26/2009 | CVIG | Kaman files $200 million shelf registration covering debt, preferreds
|
| 11/27/2007 | CV | Kaman to redeem its 6% convertibles
|
